Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
scientific article published on 19 June 2014
Author/s
author: Juan Valle, David Cunningham, Victoria E Shaw, John P Neoptolemos, Tamas Hickish, Trevor F Cox, Eithne Costello, Srinivasan Madhusudan, Dean J Naisbitt, William Greenhalf, Gary Middleton, Jonathan Wadsley, David Propper, Stephen Falk, Fareeda Coxon, Nick Wadd, Pippa G Corrie, Charlotte L Rawcliffe, Alan Anthoney, Martin Eatock
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.